DNA 메틸화 시장의 성장 요인은 무엇인가요?

암 및 기타 만성 질환의 유병률 증가가 주로 시장 성장을 이끌고 있습니다. 예를 들어, 2025년에는 미국에서 약 204만 건의 신규 암 사례가 진단될 것으로 예상됩니다.

DNA 메틸화 시장의 주요 기술은 무엇인가요?

PCR 기반 기술, 마이크로어레이 기반 기술, 시퀀싱 기반 기술 등이 주요 기술로 포함됩니다.

DNA 메틸화 시장의 주요 용도는 무엇인가요?

주요 용도로는 종양학, 신경질환, 줄기세포 연구 등이 있습니다.

DNA 메틸화 시장의 주요 기업은 어디인가요?

New England Biolabs, Abcam Limited, F. Hoffmann-La Roche Ltd, Diagenode Diagnostics SA, Thermo-Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., QIAGEN, Active Motif, Inc., Illumina Inc. 등이 있습니다.

시장보고서

상품코드

1869593

세계의 DNA 메틸화 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 테크닉별, 용도별, 최종 용도별, 지역별 부문 예측(2025-2033년)

DNA Methylation Market Size, Share & Trends Analysis Report By Product & Service, By Technique, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 10월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

DNA 메틸화 시장 요약

세계의 DNA 메틸화 시장 규모는 2024년 16억 4,000만 달러로, 2033년까지 55억 2,000만 달러에 이를 것으로 예측됩니다.

2025년부터 2033년까지 연평균 복합 성장률(CAGR) 14.73%로 성장할 전망입니다. 암 및 기타 만성 질환의 유병률 증가는 주로 시장 성장을 이끌고 있습니다.

예를 들어 미국 국립암연구소(NCI)에 따르면 2025년에는 미국에서 약 204만건의 신규암 사례가 진단될 것으로 예측되고 있으며, 이 질환에 의한 사망자 수는 추정 61만 8,120명에 이를 것으로 전망되고 있습니다.

자주 묻는 질문

DNA 메틸화 시장의 규모는 어떻게 변할 것으로 예상되나요?
- 2024년에는 16억 4,000만 달러, 2033년까지 55억 2,000만 달러에 이를 것으로 예측됩니다. 2025년부터 2033년까지 연평균 복합 성장률(CAGR)은 14.73%로 성장할 전망입니다.
DNA 메틸화 시장의 성장 요인은 무엇인가요?
- 암 및 기타 만성 질환의 유병률 증가가 주로 시장 성장을 이끌고 있습니다. 예를 들어, 2025년에는 미국에서 약 204만 건의 신규 암 사례가 진단될 것으로 예상됩니다.
DNA 메틸화 시장의 주요 기술은 무엇인가요?
- PCR 기반 기술, 마이크로어레이 기반 기술, 시퀀싱 기반 기술 등이 주요 기술로 포함됩니다.
DNA 메틸화 시장의 주요 용도는 무엇인가요?
- 주요 용도로는 종양학, 신경질환, 줄기세포 연구 등이 있습니다.
DNA 메틸화 시장의 주요 기업은 어디인가요?
- New England Biolabs, Abcam Limited, F. Hoffmann-La Roche Ltd, Diagenode Diagnostics SA, Thermo-Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., QIAGEN, Active Motif, Inc., Illumina Inc. 등이 있습니다.

지역 대시보드
시장 규모와 예측 및 동향 분석, 2021-2033년
북미
- 북미의 DNA 메틸화 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
유럽
- 유럽 DNA 메틸화 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 아시아태평양의 DNA 메틸화 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 라틴아메리카의 DNA 메틸화 시장, 2021-2033년
- 브라질
- 아르헨티나
중동 및 아프리카
- MEA DNA 메틸화 시장, 2021-2033년
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

기업 분류
전략 매핑
기업시장 포지셔닝 분석, 2024년
기업 프로파일/상장 기업
- New England Biolabs
- Abcam Limited
- F. Hoffmann-La Roche Ltd
- Diagenode Diagnostics SA
- Thermo-Fisher Scientific Inc.
- Agilent Technologies Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Active Motif, Inc.
- Illumina Inc.

JHS

DNA Methylation Market Summary

The global DNA methylation market size was estimated at USD 1.64 billion in 2024 and is projected to reach USD 5.52 billion by 2033, growing at a CAGR of 14.73% from 2025 to 2033. The rising prevalence of cancer and other chronic diseases primarily drives market growth.

For instance, according to the National Cancer Institute, in 2025, approximately 2.04 million new cancer cases are expected to be diagnosed in the U.S., with an estimated 618,120 deaths projected to result from the disease.

Global DNA Methylation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global DNA methylation market on the basis of product & services, technique, application, end-use, and region:

Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
Kits & Reagents
Instruments
Services
Technique Outlook (Revenue, USD Million, 2021 - 2033)
PCR-Based Techniques
Sequencing-Based Techniques
Microarray-Based Techniques
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Oncolgy
Neurological Disorders
Stem Cell Research
Others
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Laboratories
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product & Service
- 1.2.2. Technique
- 1.2.3. Application
- 1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Market Driver Impact Analysis
  - 3.3.1.1. Advancements in epigenetic research
  - 3.3.1.2. Advancements in sequencing and analytical technologies
- 3.3.2. Market Restraint Impact Analysis
  - 3.3.2.1. High cost and technical complexity
  - 3.3.2.2. Uncertainty in regulatory frameworks
3.4. Business Environment Analysis
- 3.4.1. PESTLE Analysis
- 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product & Service Business Analysis

4.1. Product Segment Dashboard
4.2. Global DNA Methylation Market Product & Service, Movement Analysis
4.3. Global DNA Methylation Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Kits & Reagents
- 4.4.1. Global kits & reagents market estimates and forecasts, 2021 - 2033 (USD million)
4.5. Instruments
- 4.5.1. Global instruments market estimates and forecasts, 2021 - 2033 (USD million)
4.6. Services
- 4.6.1. Global services market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 5. Technique Business Analysis

5.1. Technique Segment Dashboard
5.2. Global DNA Methylation Market Technique, Movement Analysis
5.3. Global DNA Methylation Market Size & Trend Analysis, by Technique, 2021 to 2033 (USD Million)
5.4. PCR-Based Techniques
- 5.4.1. Global PCR-Based techniques market estimates and forecasts, 2021 - 2033 (USD million)
5.5. Microarray-Based Techniques
- 5.5.1. Global microarray-based techniques market estimates and forecasts, 2021 - 2033 (USD million)
5.6. Sequencing -based techniques
- 5.6.1. Global sequencing-based techniques market estimates and forecasts, 2021 - 2033 (USD million)
5.7. Others
- 5.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 6. Application Business Analysis

6.1. Application Segment Dashboard
6.2. Global DNA Methylation Market Application, Movement Analysis
6.3. Global DNA Methylation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Oncology
- 6.4.1. Global oncology market estimates and forecasts, 2021 - 2033 (USD million)
6.5. Neurological Disorders
- 6.5.1. Global neurological disorders market estimates and forecasts, 2021 - 2033 (USD million)
6.6. Stem Cell Research
- 6.6.1. Global stem cell research market estimates and forecasts, 2021 - 2033 (USD million)
6.7. Others
- 6.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. End Use Business Analysis

7.1. End Use Segment Dashboard
7.2. Global DNA Methylation Market End Use, Movement Analysis
7.3. Global DNA Methylation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospital & Clinical Laboratories
- 7.4.1. Global hospital & clinical laboratories market estimates and forecasts, 2021 - 2033 (USD million)
7.5. Pharmaceutical & Biotechnology Companies
- 7.5.1. Global pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD million)
7.6. Academic & Research Institutes
- 7.6.1. Global academic & research institutions market estimates and forecasts, 2021 - 2033 (USD million)
7.7. Others
- 7.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 8. DNA Methylation Market: Regional Estimates and Trend Analysis, by Product, Technique, Application, & End Use

8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. North America
- 8.3.1. North America DNA methylation market, 2021 - 2033 (USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. U.S. DNA methylation market, 2021 - 2033 (USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Canada DNA methylation market, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Competitive Scenario
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. Mexcio DNA methylation market, 2021 - 2033 (USD Million)
8.4. Europe
- 8.4.1. Europe DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.2. UK
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. UK DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.3. Germany
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Germany DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.4. France
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. France DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.5. Italy
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Italy DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.6. Spain
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Spain DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Denmark DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
  - 8.4.8.1. Key Country Dynamics
  - 8.4.8.2. Competitive Scenario
  - 8.4.8.3. Regulatory Framework
  - 8.4.8.4. Sweden DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.9. Norway
  - 8.4.9.1. Key Country Dynamics
  - 8.4.9.2. Competitive Scenario
  - 8.4.9.3. Regulatory Framework
  - 8.4.9.4. Norway DNA methylation market, 2021 - 2033 (USD Million)
8.5. Asia Pacific
- 8.5.1. Asia Pacific DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.2. Japan
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Japan DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.3. China
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. China DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.4. India
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. India DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.5. Australia
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Australia DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.6. Thailand
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Thailand DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.7. South Korea
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. South Korea DNA methylation market, 2021 - 2033 (USD Million)
8.6. Latin America
- 8.6.1. Latin America DNA methylation market, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Brazil DNA methylation market, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Argentina DNA methylation market, 2021 - 2033 (USD Million)
8.7. MEA
- 8.7.1. MEA DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. South Africa DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.3. Saudi Arabia
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Saudi Arabia DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.4. UAE
  - 8.7.4.1. Key Country Dynamics
  - 8.7.4.2. Competitive Scenario
  - 8.7.4.3. Regulatory Framework
  - 8.7.4.4. UAE DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
  - 8.7.5.1. Key Country Dynamics
  - 8.7.5.2. Competitive Scenario
  - 8.7.5.3. Regulatory Framework
  - 8.7.5.4. Kuwait DNA methylation market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
- 9.4.1. New England Biolabs
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. Abcam Limited
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. F. Hoffmann-La Roche Ltd
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. Diagenode Diagnostics S.A.
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Thermo-Fisher Scientific Inc.
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Agilent Technologies Inc.
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Bio-Rad Laboratories, Inc.
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. QIAGEN
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Active Motif, Inc.
  - 9.4.9.1. Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. Illumina Inc.
  - 9.4.10.1. Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives

세계의 DNA 메틸화 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 테크닉별, 용도별, 최종 용도별, 지역별 부문 예측(2025-2033년)

DNA Methylation Market Size, Share & Trends Analysis Report By Product & Service, By Technique, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

DNA 메틸화 시장 요약

자주 묻는 질문

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장의 변수, 동향, 범위

제4장 제품 및 서비스별 비즈니스 분석

제5장 기술별 비즈니스 분석

제6장 용도별 비즈니스 분석

제7장 최종 용도별 비즈니스 분석

제8장 DNA 메틸화 시장 : 제품, 테크닉, 용도, 최종 용도별 지역 추정 및 동향 분석